Chester County News and Community Website
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is set to showcase critical new findings on resmetirom, its liver-targeted thyroid hormone receptor (THR)-β agonist, at the European Association for the …
Madrigal Pharmaceuticals to Present Breakthrough Resmetirom Data at EASL Congress 2025 Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced a key leadership transition as founder and Chief Medical Officer Dr. Rebecca Taub steps into the role of Senior Scientific …
Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced the appointment of Jacqualyn (“Jackie”) Fouse, Ph.D., to its Board of Directors, bringing decades of leadership and expertise in the biotech …
Madrigal Pharmaceuticals Announces Changes to Board of Directors Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced its financial results for 2024, marking a pivotal year highlighted by the FDA approval and successful launch of Rezdiffra (resmetirom). Rezdiffra, …
Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced positive two-year results from the Phase 3 MAESTRO-NAFLD-1 trial, demonstrating the potential of Rezdiffra (resmetirom) to significantly reduce liver stiffness in …
Madrigal Pharmaceuticals Reports Promising Two-Year Results for MASH Therapy Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced its participation in the 45th Annual TD Cowen Health Care Conference, scheduled to take place on Tuesday, March 4, 2025, …
Madrigal Pharmaceuticals to Present at 45th Annual TD Cowen Health Care Conference Read More